Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

洛度沙胺氨丁三醇滴眼液 - NMPA Drug Approval Details

Approvals/NMPA/Lodoxamide Tromethamine Eye Drops

Approved

化学药品

Lodoxamide Tromethamine Eye Drops

武汉先路医药科技股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 10, 2024
Approval ID: 8fOLkzpjGly
Company: 武汉先路医药科技股份有限公司
Type: 化学药品

Approval Details

Approval Id: 8fOLkzpjGly
Approval Number: 国药准字H20249725
Generic Name: 洛度沙胺氨丁三醇滴眼液
Generic Name En: Lodoxamide Tromethamine Eye Drops
Drug Type: 化学药品
Dosage Form: 眼用制剂
Strength: 0.1%（5ml:5mg，按C₁₁H₆ClN₃O₆计）
Reg Date: 2024-12-10
Company Name: 武汉先路医药科技股份有限公司
Company Address: 湖北省武汉市东湖新技术开发区高新大道858号生物医药园A7展示中心
Production Company Name: 四川禾亿制药有限公司
Production Company Address: 四川省成都市蒲江县鹤山街道工业南路67号
Company Detail Path: /organization/c0ff6c5570f898e6/wu-yi-xian-lu-yi-yao-ke-ji-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/46e38b14555670e9/si-chuan-he-yi-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 10, 2024

Approval ID

8fOLkzpjGly

Type

化学药品

Back to NMPA Approvals